Ballymore Resources Limited (ASX:BMR) has submitted an application to list 4,000,000 new fully paid ordinary shares on the ASX, each priced at $0.125 and dated 3 July 2026. These shares are part of a placement originally announced in an Appendix 3B lodged on 19 June 2026. With this quotation, the company’s total ordinary shares on issue will rise to 247,725,266. Investors remain attentive as an additional 2,000,000 free-attaching options are yet to be issued to finalize the placement.
Key Points
- Company: Ballymore Resources Limited (ASX:BMR)
- Application for quotation of 4,000,000 fully paid ordinary shares on 3 July 2026
- Shares issued at $0.125 each (AUD) for cash consideration
- Shares relate to a placement first disclosed on 19 June 2026
- Total ordinary shares after quotation: 247,725,266
- Outstanding 2,000,000 free-attaching options exercisable at $0.22, expiring 31 December 2028 (ASX:BMRAL) to be issued to complete placement
- Investors should monitor the issuance of the remaining options and any further capital updates from the company
Ballymore Resources Files to Quote 4 Million Placement Shares at $0.125 Each
On 3 July 2026, Ballymore Resources Limited lodged an Appendix 2A with the ASX requesting the quotation of 4,000,000 fully paid ordinary shares issued at $0.125 each. The shares were issued for cash in Australian dollars, with the quotation date matching the application lodgement date. This step formalizes the availability of these securities for trading, following their initial announcement via a proposed issue notice on 19 June 2026.
The $0.125 issue price provides a reference for the placement relative to market conditions at issuance. The company did not disclose the total gross proceeds raised or the identities of investors involved. The immediate impact on the share price is unclear from public information, though the new shares will increase liquidity in BMR’s ordinary share register from the issue date.
Placement Structure and Market Notification in June 2026
The shares were issued under a placement arrangement first notified to the ASX on 19 June 2026 at 17:07 via a prospective Appendix 3B titled "New - Proposed issue of securities - BMR." The Appendix 2A lodged on 3 July 2026 serves as the follow-up quotation request, confirming the shares have been formally issued and are ready for trading.
This two-step process—initial Appendix 3B notification followed by Appendix 2A quotation—is standard under ASX Listing Rules. It provides the market with advance notice of dilution before trading begins. The approximately two-week interval between notification and quotation aligns with typical settlement and administrative timelines.
Outstanding Free-Attaching Options at $0.22 to Complete Placement
The Appendix 2A reveals that the placement is not yet fully complete. An additional 2,000,000 free-attaching options remain to be issued, exercisable at $0.22 each and expiring on 31 December 2028 under ASX code BMRAL. These options were granted at no extra cost alongside the shares.
Free-attaching options are commonly used in junior resource placements to incentivize investors by offering upside potential if the share price exceeds the exercise price before expiry. Here, the $0.22 exercise price is a premium over the $0.125 placement price. The company has not provided a timeline for issuing or quoting these options; investors should watch for future Appendix 3B and 2A filings related to BMRAL options.
Total Share Count Rises to 247.7 Million Following Quotation
With the listing of the 4,000,000 new shares, Ballymore Resources’ total quoted ordinary shares now stand at 247,725,266. This figure, generated by ASX systems via the Appendix 2A, may not fully reflect the current issued capital if other forms are concurrently processed.
The increase represents a modest addition relative to the existing share base. Although the pre-placement share count was not disclosed here, the post-quotation total offers a baseline for investors assessing ownership percentages and dilution effects from the placement.
Unquoted Securities Include Multiple Option Tranches and Performance Rights
Beyond quoted shares, Ballymore Resources holds significant unquoted securities. As detailed in Part 4.2 of the Appendix 2A, these include 2,050,000 performance rights (ASX:BMRAJ), 20,410,143 options expiring 31 December 2028 at $0.22 (ASX:BMRAL), 9,788,684 options expiring 31 December 2027 at $0.22 (ASX:BMRAI), and 7,000,000 options expiring 30 June 2027 at $0.20 (ASX:BMRAH).
The 20,410,143 BMRAL options include previously issued tranches, with the forthcoming 2,000,000 options from the current placement adding to this total. Collectively, these unquoted options and performance rights represent potential dilution if exercised or vested, an important consideration for investors evaluating the company’s fully diluted capital structure. No further details on exercise or vesting schedules beyond expiry dates were provided.
Implications of the $0.125 Placement Price for Ballymore Resources’ Capital Raising
The $0.125 per share price for the 4,000,000 placement shares offers insight into the terms under which Ballymore Resources raised capital in mid-2026. Typically, junior resource placements are priced at a discount to market to attract institutional or sophisticated investors. The company did not disclose the prevailing market price at placement, so the exact discount cannot be confirmed from this filing.
This Appendix 2A is procedural and does not address the placement’s rationale, use of proceeds, or whether it was part of a larger funding round. Investors seeking more information should refer to the original 19 June 2026 placement announcement or any related investor presentations.
Role of Performance Rights in Ballymore Resources’ Incentive Framework
The company holds 2,050,000 performance rights under code BMRAJ, a common equity-based remuneration tool aligning management and key personnel interests with shareholders. These rights typically vest upon meeting performance or service conditions and convert into ordinary shares.
No details on vesting criteria or recipients were disclosed in this update. While unquoted and non-tradeable immediately, these rights represent potential future dilution upon vesting. Further information may be found in Ballymore Resources’ annual reports or meeting notices.
Key Developments for Investors Following Share Quotation
With the 4,000,000 placement shares now formally applied for quotation, investor focus will likely shift to two areas. First, the issuance and listing of the remaining 2,000,000 free-attaching BMRAL options, which will require separate Appendix 2A filings before trading.
Second, investors will look for updates on how funds raised are deployed within Ballymore Resources’ operations or exploration activities. This procedural update contains no operational commentary; substantive news would be released via separate market announcements. The next important milestones include completion of the free-attaching options issuance and any forthcoming operational updates.